Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells
Authors:
- 5 August 2005
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 13 (2) , 202-211
Abstract
Recent studies have suggested that 5-aminosalicylic acid (5-ASA) inhibits colorectal cancer (CRC) development. However, the mechanism underlying the antineoplastic effect of 5-ASA remains unknown. We here examined the effect of 5-ASA on epidermal growth factor receptor (EGFR) activation, a pathway that triggers mitogenic signals in CRC cells. We show that 5-ASA inhibits EGFR activation, through a mechanism that does not rely on CRC cell death induction. 5-ASA enhances the activity, but not expression, of phosphorylated (p)-EGFR-targeting phosphatases (PTPs), and treatment of cells with PTP inhibitors abrogates the 5-ASA-mediated EGFR dephosphorylation. Both SH-PTP1 and SH-PTP2 interact with EGFR upon 5-ASA treatment. However, knockdown of SH-PTP2 but not SH-PTP1 by small interference RNAs prevents the 5-ASA-induced EGFR dephosphorylation. Finally, we show that 5-ASA attenuates p-EGFR in ex vivo organ cultures of CRC explants. Data indicate that 5-ASA disrupts EGFR signalling by enhancing SH-PTP2 activity, and suggest a mechanism by which 5-ASA interferes with CRC growth.Keywords
This publication has 32 references indexed in Scilit:
- Risk of cardiovascular events and rofecoxib: cumulative meta-analysisThe Lancet, 2004
- Prevention by Intrarectal 5-Aminosalicylic Acid of N -Methylnitrosourea-Induced Colon Cancer in F344 RatsDiseases of the Colon & Rectum, 2003
- Epidermal growth factor receptor: mechanisms of activation and signallingExperimental Cell Research, 2003
- Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesisProceedings of the National Academy of Sciences, 2002
- The EGF receptor family as targets for cancer therapyOncogene, 2000
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000
- Colorectal Cancer and Nonsteroidal Anti-inflammatory Drugs1997
- Recent advances in the management of colorectal polypsCurrent Opinion in Gastroenterology, 1996
- Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation.Molecular and Cellular Biology, 1994
- Increased Expression of the Epidermal Growth Factor Receptor on Human Colon Carcinoma CellsArchives of Surgery, 1986